Sapropterin Expanded Access Program
NCT00484991
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Phenylketonuria
Interventions
DRUG:
Sapropterin dihydrochloride
Sponsor
BioMarin Pharmaceutical